| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CASH DIVIDEND/DISTRIBUTION::MANDATORY | 1 | SGX Company Announcements | ||
| TIANJIN PHARMACEUTICAL DA REN TANG Aktie jetzt für 0€ handeln | |||||
| 03.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF THE ANNUAL GENERAL MEETING OF THE COMPANY HELD ON 15 MAY 2026 | - | SGX Company Announcements | ||
| 02.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE | - | SGX Company Announcements | ||
| 02.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | - | SGX Company Announcements | ||
| 19.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED TRANSFER OF 100% EQUITY INTEREST IN AN UPSTREAM SHAREHOLDER | 1 | SGX Company Announcements | ||
| 15.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::ANNOUNCEMENT OF APPOINTMENT | 1 | SGX Company Announcements | ||
| 15.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::ANNOUNCEMENT OF CESSATION | 1 | SGX Company Announcements | ||
| 15.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 5 | SGX Company Announcements | ||
| 11.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 30.04. | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Increase In Q1 Income | 3 | RTTNews | ||
| 30.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 2 | SGX Company Announcements | ||
| 30.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 30.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 2 | SGX Company Announcements | ||
| 29.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE EVALUATION REPORT ON THE 2025 ACTION PLAN AND THE ADOPTION OF THE 2026 ACTION PLAN | - | SGX Company Announcements | ||
| 29.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 4TH BOARD MEETING FOR FY2026 | - | SGX Company Announcements | ||
| 29.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FIRST QUARTER RESULTS | - | SGX Company Announcements | ||
| 16.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 16.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 3RD BOARD MEETING FOR FY2026 | 2 | SGX Company Announcements | ||
| 02.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::INTERESTED PERSON TRANSACTION::THE PROPOSED PROVISION OF A GUARANTEE FOR AN INTERESTED PERSON TRANSACTION | - | SGX Company Announcements | ||
| 31.03. | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Full Year Income Retreats | 2 | RTTNews |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 154,60 | +2,32 % | JEFFERIES stuft ASTRAZENECA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Astrazeneca mit einem Kursziel von 18000 Pence auf "Buy" belassen. Die Briten seien die einzige europäische Pharmagröße... ► Artikel lesen | |
| TEVA | 27,500 | -2,48 % | Teva Pharmaceutical Industries Ltd: Teva Releases Q2 2026 Aide Memoire | TEL AVIV, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2026 Aide Memoire is available on the "Investors" page on its... ► Artikel lesen | |
| SINOPHARM | 1,830 | -1,43 % | SINOPHARM (01099): PROPOSED DISTRIBUTION OF FINAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS (UPDATED) | ||
| CSPC PHARMA | 0,769 | -2,18 % | CSPC PHARMA (01093): FURTHER ANNOUNCEMENT - UPDATE ON DISCLOSEABLE TRANSACTION IN RELATION TO THE PROPOSED H SHARE LISTING OF CSPC INNOVATION | ||
| WUXI BIOLOGICS | 3,455 | +1,77 % | WUXI BIO (02269): NEXT DAY DISCLOSURE RETURN | ||
| OPKO HEALTH | 1,250 | +0,81 % | OPKO HEALTH, INC. - 8-K, Current Report | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 1,712 | -1,47 % | FOSUN PHARMA (02196): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 | ||
| GEDEON RICHTER | 33,120 | +0,06 % | Gedeon Richter Plc.: Deadline Extended for 2026 Semmelweis-Richter Journalism Award Applications | Following strong interest and numerous requests, the application deadline for the 2026 Semmelweis-Richter Journalism Award has been extended by two weeks. Submissions are now accepted until June 23... ► Artikel lesen | |
| DR REDDYS | 12,000 | +5,26 % | Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy's for XACDURO in Select International Markets | Agreement expands access to XACDURO for patients with serious Acinetobacter baumannii-calcoaceticus complex (Acinetobacter) infections across South and Central America, the Caribbean, Russia... ► Artikel lesen | |
| BAYER | 38,010 | +2,31 % | EQS-PVR: Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Bayer Aktiengesellschaft
Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
15.06.2026... ► Artikel lesen | |
| MERCK KGAA | 133,30 | +0,19 % | JEFFERIES stuft MERCK KGAA auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Merck KGaA auf "Hold" mit einem Kursziel von 129 Euro belassen. Das Segment Life Science sei ein wesentlicher, mit geringeren... ► Artikel lesen | |
| NOVO NORDISK | 40,330 | +3,41 % | Novo Nordisk: Das sieht jetzt gar nicht mal so schlecht aus! | Die Aktie von Novo Nordisk handelte in den vergangenen Wochen unauffällig. Geschadet hat ihr das nicht, wie ein erfolgreicher Test der 50-Tage-Linie zeigt. Novo Nordisk schaut dem Markt noch immer hinterher... ► Artikel lesen | |
| CDT EQUITY | 1,560 | +52,94 % | CDT Equity's Sarborg stake valued at $127.5M after fundraise | ||
| SANOFI | 72,67 | -2,11 % | DEUTSCHE BANK RESEARCH stuft SANOFI auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Sanofi von 100 auf 95 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Emmanuel Papadakis beschäftigte sich in seinem... ► Artikel lesen | |
| PFIZER | 21,960 | -0,95 % | Pfizer-Finanzchef geht im August | NEW YORK (dpa-AFX) - Pfizer steht vor einem Wechsel im Finanzressort. Wie der US-Pharmakonzern am Donnerstag in New York mitteilte, wird Finanzvorstand Dave Denton sein Amt zum 15. August niederlegen... ► Artikel lesen |